KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Cash from Financing Activities (2016 - 2026)

Chemed filings provide 18 years of Cash from Financing Activities readings, the most recent being -$108.1 million for Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 359.21% year-over-year to -$108.1 million, compared with a TTM value of -$517.3 million through Mar 2026, down 40.97%, and an annual FY2025 reading of -$432.8 million, down 20.48% over the prior year.
  • Cash from Financing Activities hit -$108.1 million in Q1 2026 for Chemed, up from -$172.8 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was -$263000.0 in Q3 2023, with the low at -$212.5 million in Q4 2024.
  • Median Cash from Financing Activities over the past 5 years was -$53.4 million (2022), compared with a mean of -$69.9 million.
  • The sharpest move saw Cash from Financing Activities skyrocketed 99.34% in 2023, then plummeted 21365.02% in 2024.
  • Year by year, Cash from Financing Activities stood at -$14.4 million in 2022, then skyrocketed by 57.64% to -$6.1 million in 2023, then plummeted by 3392.1% to -$212.5 million in 2024, then increased by 18.67% to -$172.8 million in 2025, then soared by 37.46% to -$108.1 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$108.1 million, -$172.8 million, and -$189.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.